Results 271 to 280 of about 136,697 (349)

What anabolic–androgenic steroids reveal about the limits of current harm reduction models

Addiction, EarlyView.
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski, Jason M. Nagata, Suzanne Nielsen   +2 more
wiley   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

Collaborative Care for Opioid Use Disorder and Mental Illness: The CLARO Randomized Clinical Trial.

JAMA Intern Med
Watkins KE, Osilla KC, McCullough CM, Griffin BA, Dopp AR, Becker K, Meredith LS, Carrejo V, Hindmarch GM, Mendon-Plasek S, Christensen J, Weir R, Kelly L, Pak L, Murray-Krezan C, Tarhuni L, Crowley C, Bilder A, Kalmin MM, Schoenbaum M, Komaromy M.   +20 more
europepmc   +1 more source

Burden of overdoses among persons with opioid use disorder in the United States, 2025-2028: a simulation modeling study. [PDF]

Lancet Reg Health Am
Nataraj N, Chen Y, Stewart A, Rikard SM, Zhang K, Rice K, Jiang X, Mattson CL, Ko J, Guy GP, Losby JL.   +10 more
europepmc   +1 more source

Data Sheet 1_The intersection of aging, pain, and opioid use disorder: a retrospective chart review from an outpatient opioid treatment clinic.pdf

Bethea A. Kleykamp (22267534), Hannah Smith (3310815), Erin Lynch (12305084), Aaron Greenblatt (22267537), Eric Weintraub (4689943)   +4 more
openalex   +1 more source

Editorial: Reviews in opioid use disorders [PDF]

Wendy Walwyn, Kirk E. Evoy
openalex   +1 more source

The association between sleep disturbance and stimulant use: A cross‐lagged examination

Addiction, EarlyView.
Abstract Background and aims Sleep disruptions increase the risk of substance misuse. Substance use—especially stimulants—can increase acute and chronic sleep dysfunction. This study aimed to estimate the associations between sleep disturbance and stimulant use over time among participants with stimulant use disorder (StUD).
Viviana E. Horigian, Renae D. Schmidt, Daniel J. Feaster, Rui Duan, Sophia T. Gonzalez, Kathryn Hefner, Dikla Shmueli‐Blumberg, Ashley Vena, Landhing M. Moran, Chloe A. DiCamillo, Shirin Shafazand, Susan Tross, Judith Feinberg   +12 more
wiley   +1 more source

Retention Challenges in Opioid Use Disorder Treatment: The Role of Comorbid Psychological Conditions. [PDF]

West J Emerg Med
Yuan S, Li ZL, Hu J.
europepmc   +2 more sources

Genetic and Epigenetic Approaches to Opioid Use Disorder. [PDF]

Expert Rev Mol Med
Ranadeva ND, Wijekumar PJ, Fernando CA, Jayamaha AR, Noordeen N, Chackrewarthy S, Fernando N.   +6 more
europepmc   +1 more source